Doug Giordano, MBA
Doug Giordano is former Senior Vice President of Pfizer Worldwide Business Development Group. Since 2007, Doug has been responsible for leading Pfizer’s evaluation, negotiation, and execution of product licensing, partnerships, and M&A transactions. Under Doug’s leadership, Pfizer has deployed over $125B of capital to business development across a wide range of transaction types from venture investing, biotech licensing through large scale M&A. Doug also led Pfizer’s IPO/split off of Zoetis, Pfizer’s consumer JV with GSK and the recently closed spin/merger of Viatris. Doug will be leaving Pfizer in 1Q21.
Before leading Pfizer’s Worldwide Business Development group, Doug held positions of increasing responsibility within Pfizer’s U.S. Pharmaceuticals Group including roles in finance, manufacturing, and commercial strategy. Prior to joining Pfizer, Doug was a consultant at Booz, Allen & Hamilton.
Doug earned a bachelor’s degree in biomedical engineering from Duke University and an M.B.A. from Cornell University’s Johnson School of Business. He currently serves on the Board of Cerevel Therapeutics.
Doug resides in New Jersey with his wife and two children. His favorite vacation would involve diving, catching lobster, and shooting fish. He doesn’t get to do it enough.